8-K
Current Report
Oruka Therapeutics, Inc. Filed Acc 0001213900-24-060156
Material agreement
- Item 1.01 Entry into a material definitive agreement
From the SEC's structured data for this filing
Loading ea0209134-8k425_arcabio.htm…